Synera Venipuncture Pain
NCT01744197
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
61
Enrollment
INDUSTRY
Sponsor class
Conditions
Pain
Phlebotomy
Palliative Care
Interventions
DRUG:
Synera (lidocaine 70mg/tetracaine 70mg)
Sponsor
US Oncology Research
Collaborators
[object Object]